“…Recent studies have reported that routine complete blood count (CBC) components, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR) could be used as novel markers of systemic inflammatory response in various medical conditions, including pregnancy complications, [19][20][21][22][23][24][25][26][27][28][29] cancers, 30,31 cerebral hemorrhage, 32,33 ischemic stroke, [34][35][36] major cardiac events, 37,38 sepsis and infectious pathologies 39,40 and other diseases, in which these inexpensive and readily available inflammatory markers can help to stratify patient risks and individualize treatment strategy during everyday clinical practice. In particular, increasing evidence indicates that these inflammatory markers, such as NLR, MLR and neutrophil count, may be useful in predicting the risk of developing preeclampsia and invasion of gestational trophoblastic disease, and diagnosing HELLP syndrome, gestational diabetes mellitus, intrahepatic cholestasis of pregnancy, as well as hyperemesis gravidarum.…”